Praxis Precision Medicines PRAX
NASDAQ PRAX
$300.65 +1.78 (+0.60%)
At close: Sep 22, 2026 · 4:00 PM EDT

Praxis Precision Medicines (PRAX) Interest & Investment Income (2019 - 2026)

Praxis Precision Medicines (PRAX) posted Interest & Investment Income of -$1.1 million for Q2 2026, up 50.02% on a QoQ basis from -$2.2 million in Q1 2026, and down 308.33% year-over-year from $517440.0 in Q2 2025.

Analysis

Praxis Precision Medicines (PRAX) Interest & Investment Income (2019 - 2026) Analysis & Trends

Praxis Precision Medicines has reported Interest & Investment Income for 8 years, with the latest figure at -$1.1 million in Q2 2026.

  • On a quarterly basis, Interest & Investment Income fell 308.33% year-over-year to -$1.1 million in Q2 2026; TTM through Jun 2026 was -$3.5 million, a 426.85% decrease from a year earlier, with the FY2022 full-year figure at $957000.0, up 253.14% from the prior year.
  • Interest & Investment Income was -$1.1 million for Q2 2026 at Praxis Precision Medicines, up from -$2.2 million in the prior quarter.
  • The five-year high for Interest & Investment Income was $1.4 million in Q3 2024, with the low at -$2.2 million in Q1 2026.
  • Average Interest & Investment Income over 5 years is -$79461.5, with a median of $3000.0 recorded in 2024.
  • The sharpest annual moves came in 2023 and 2026: Interest & Investment Income surged 135.81% in 2023, then slumped 43240.0% in 2026.
  • Over 5 years, Interest & Investment Income stood at $1.3 million in 2022, then plunged by 98.56% to $19000.0 in 2023, then jumped by 7278.95% to $1.4 million in 2024, then tumbled by 118.83% to -$264000.0 in 2025, then slumped by 308.33% to -$1.1 million in 2026.
  • The last three Interest & Investment Income figures came in at -$1.1 million (Q2 2026), -$2.2 million (Q1 2026), and -$264000.0 (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Amgen 212.54 Bn 198.55 Bn 7.24 Bn -
2 Gilead Sciences 186.84 Bn 183.58 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 129.39 Bn 121.54 Bn 2.84 Bn 120.60 Mn
4 Regeneron Pharmaceuticals 82.05 Bn 74.06 Bn 3.93 Bn -48.00 Mn
5 Moderna 69.00 Bn 63.87 Bn 52.00 Mn 67.00 Mn
6 Argenx Se 61.15 Bn 55.97 Bn 1.37 Bn 48.00 Mn
7 Alnylam Pharmaceuticals 32.67 Bn 29.37 Bn 992.69 Mn 28.14 Mn
8 Biogen 32.37 Bn 31.08 Bn 1.96 Bn -
9 Roivant Sciences 28.18 Bn 28.87 Bn 1.16 Mn 36.92 Mn
10 Praxis Precision Medicines 8.34 Bn 7.58 Bn - -1.08 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.08 Mn
Mar 31, 2026 -2.16 Mn
Jun 30, 2025 -264,000.00
Mar 31, 2025 5,000.00
Sep 30, 2024 1.40 Mn
Jun 30, 2024 -74,000.00
Mar 31, 2024 3,000.00
Jun 30, 2023 19,000.00
Mar 31, 2023 154,000.00
Dec 31, 2022 1.32 Mn
Sep 30, 2022 144,000.00
Jun 30, 2022 -74,000.00
Mar 31, 2022 -430,000.00
Jun 30, 2021 36,000.00
Mar 31, 2021 -86,000.00
Dec 31, 2020 6,000.00
Sep 30, 2020 1,000.00
Mar 31, 2020 128,000.00
Dec 31, 2019 22,000.00
Sep 30, 2019 48,000.00
API Access

Praxis Precision Medicines Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=PRAX&period=max&api_key=YOUR_API_KEY